Dr. Raymond Jaihyun Cho, MD, PhD

Dr. Cho practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Cho's NPI, 1790999175, was assigned on May 9, 2007. Dr. Cho graduated from Stanford University School Of Medicine in 2005. Dr. Cho holds California license 96916.

Dr. Cho's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Cho's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Cho to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cho practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Cho's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Cho is board certified in dermatology by the American Board of Dermatology. Dr. Cho is licensed in California.

Dmand AI lists acne, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, hives, itchy rashes, minor injury on trunk and psoriasis among the conditions Dr. Cho treats.

CMS data shows 1,696 Medicare services from Dr. Cho across 14 procedure codes in 2024, for 357 Medicare patients. Medicare paid $67,317 for them. Every service was in an office.

CMS counts 357 Medicare patients who saw Dr. Cho in 2024. The largest group is 75 to 84, with 145 patients. 70% of them have high cholesterol, and 63% have high blood pressure. 31% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cho's median patient age at 63, with 53% women.

In 2024, Dr. Cho wrote 783 Medicare Part D claims for 235 patients. 83% of them were for generic drugs. CMS names the drug for 656 of them, across 20 drugs with 11 or more claims each, at $533,419 in total drug cost. In 2023, CMS named 571 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Cho for performance year 2024, reported as part of a group. Dr. Cho accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cho as offering telehealth. CMS counts 353 procedures of removal of skin lesions by Dr. Cho, more than 83% of the clinicians it reports for that procedure.

Dmand AI links 47 papers to Dr. Cho, published from 2011 to 2024. 2024 was the busiest year, with 6. The most frequent topics are Gene Expression Profiling, Skin Neoplasms and Carcinoma, Squamous Cell. Dr. Cho has published most often in J Invest Dermatol. Dr. Cho's most frequent co-authors are Jeffrey B. Cheng, Jon Christopher Aster, MD, PhD and Roy C. Grekin, MD.

CMS Open Payments shows 56 general payments to Dr. Cho from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 61% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,930.

Dr. Cho graduated from Stanford University School Of Medicine in 2005.

Dr. Cho is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.